Sectoral Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-6,474
| Closed | -$380K | – | 116 |
|
2023
Q4 | $380K | Sell |
6,474
-175,430
| -96% | -$10.3M | 0.16% | 87 |
|
2023
Q3 | $7.92M | Buy |
181,904
+33,351
| +22% | +$1.45M | 1.54% | 21 |
|
2023
Q2 | $5.37M | Buy |
148,553
+20,147
| +16% | +$728K | 0.89% | 52 |
|
2023
Q1 | $4.77M | Buy |
128,406
+61,560
| +92% | +$2.29M | 0.92% | 49 |
|
2022
Q4 | $3.03M | Buy |
66,846
+7,330
| +12% | +$332K | 0.59% | 68 |
|
2022
Q3 | $4.16M | Sell |
59,516
-9,097
| -13% | -$635K | 0.82% | 55 |
|
2022
Q2 | $4.61M | Buy |
68,613
+8,776
| +15% | +$589K | 0.93% | 46 |
|
2022
Q1 | $4.92M | Sell |
59,837
-16,000
| -21% | -$1.32M | 0.87% | 47 |
|
2021
Q4 | $11.1M | Buy |
75,837
+73,286
| +2,873% | +$10.8M | 1.67% | 20 |
|
2021
Q3 | $451K | Buy |
2,551
+120
| +5% | +$21.2K | 0.04% | 119 |
|
2021
Q2 | $393K | Sell |
2,431
-76,650
| -97% | -$12.4M | 0.03% | 118 |
|
2021
Q1 | $13.5M | Buy |
79,081
+5,443
| +7% | +$932K | 1.03% | 33 |
|
2020
Q4 | $16.2M | Buy |
+73,638
| New | +$16.2M | 1.14% | 33 |
|
2020
Q3 | – | Sell |
-125,336
| Closed | -$14.3M | – | 186 |
|
2020
Q2 | $14.3M | Buy |
125,336
+51,236
| +69% | +$5.85M | 1.31% | 33 |
|
2020
Q1 | $5.7M | Buy |
+74,100
| New | +$5.7M | 1.09% | 44 |
|